vs
Side-by-side financial comparison of VAALCO ENERGY INC (EGY) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $91.0M, roughly 1.0× VAALCO ENERGY INC). Vericel Corp runs the higher net margin — 25.0% vs -64.4%, a 89.4% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -25.2%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -4.7%).
VAALCO Energy is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston, Texas with operations primarily in the Etame Marin block offshore Gabon.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
EGY vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $91.0M | $92.9M |
| Net Profit | $-58.6M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | -71.3% | 24.1% |
| Net Margin | -64.4% | 25.0% |
| Revenue YoY | -25.2% | 23.3% |
| Net Profit YoY | -602.5% | 17.3% |
| EPS (diluted) | $-0.56 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $91.0M | $92.9M | ||
| Q3 25 | $61.0M | $67.5M | ||
| Q2 25 | $96.9M | $63.2M | ||
| Q1 25 | $110.3M | $52.6M | ||
| Q4 24 | $121.7M | $75.4M | ||
| Q3 24 | $140.3M | $57.9M | ||
| Q2 24 | $116.8M | $52.7M | ||
| Q1 24 | $100.2M | $51.3M |
| Q4 25 | $-58.6M | $23.2M | ||
| Q3 25 | $1.1M | $5.1M | ||
| Q2 25 | $8.4M | $-553.0K | ||
| Q1 25 | $7.7M | $-11.2M | ||
| Q4 24 | $11.7M | $19.8M | ||
| Q3 24 | $11.0M | $-901.0K | ||
| Q2 24 | $28.2M | $-4.7M | ||
| Q1 24 | $7.7M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | -71.3% | 24.1% | ||
| Q3 25 | 1.5% | 5.1% | ||
| Q2 25 | 17.7% | -3.2% | ||
| Q1 25 | 23.7% | -24.3% | ||
| Q4 24 | 32.7% | 24.5% | ||
| Q3 24 | 31.4% | -4.3% | ||
| Q2 24 | 17.5% | -11.5% | ||
| Q1 24 | 32.1% | -10.7% |
| Q4 25 | -64.4% | 25.0% | ||
| Q3 25 | 1.8% | 7.5% | ||
| Q2 25 | 8.6% | -0.9% | ||
| Q1 25 | 7.0% | -21.4% | ||
| Q4 24 | 9.6% | 26.3% | ||
| Q3 24 | 7.8% | -1.6% | ||
| Q2 24 | 24.1% | -8.9% | ||
| Q1 24 | 7.7% | -7.5% |
| Q4 25 | $-0.56 | $0.46 | ||
| Q3 25 | $0.01 | $0.10 | ||
| Q2 25 | $0.08 | $-0.01 | ||
| Q1 25 | $0.07 | $-0.23 | ||
| Q4 24 | $0.12 | $0.40 | ||
| Q3 24 | $0.10 | $-0.02 | ||
| Q2 24 | $0.27 | $-0.10 | ||
| Q1 24 | $0.07 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.9M | $137.5M |
| Total DebtLower is stronger | $60.0M | — |
| Stockholders' EquityBook value | $443.5M | $354.6M |
| Total Assets | $913.4M | $488.0M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.9M | $137.5M | ||
| Q3 25 | $24.0M | $135.4M | ||
| Q2 25 | $67.9M | $116.9M | ||
| Q1 25 | $40.9M | $112.9M | ||
| Q4 24 | $82.7M | $116.2M | ||
| Q3 24 | $89.1M | $101.7M | ||
| Q2 24 | $62.9M | $102.5M | ||
| Q1 24 | $113.3M | $110.6M |
| Q4 25 | $60.0M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $60.0M | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
| Q4 25 | $443.5M | $354.6M | ||
| Q3 25 | $505.9M | $321.9M | ||
| Q2 25 | $511.6M | $306.8M | ||
| Q1 25 | $504.1M | $295.5M | ||
| Q4 24 | $501.6M | $292.0M | ||
| Q3 24 | $501.0M | $257.5M | ||
| Q2 24 | $493.6M | $243.0M | ||
| Q1 24 | $472.6M | $233.9M |
| Q4 25 | $913.4M | $488.0M | ||
| Q3 25 | $950.4M | $453.3M | ||
| Q2 25 | $964.9M | $435.6M | ||
| Q1 25 | $927.1M | $424.6M | ||
| Q4 24 | $955.0M | $432.7M | ||
| Q3 24 | $937.9M | $390.4M | ||
| Q2 24 | $917.4M | $376.8M | ||
| Q1 24 | $809.1M | $356.7M |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $145.2M | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.2M | $15.0M | ||
| Q3 25 | $16.4M | $22.1M | ||
| Q2 25 | $18.3M | $8.2M | ||
| Q1 25 | $32.7M | $6.6M | ||
| Q4 24 | $44.5M | $22.2M | ||
| Q3 24 | $47.8M | $10.2M | ||
| Q2 24 | $-438.0K | $18.5M | ||
| Q1 24 | $21.8M | $7.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | — | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | $29.7M | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | 26.9% | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | 2.7% | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 14.94× | 4.35× | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 4.23× | — | ||
| Q4 24 | 3.82× | 1.12× | ||
| Q3 24 | 4.35× | — | ||
| Q2 24 | -0.02× | — | ||
| Q1 24 | 2.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
